Expert panel highlights opportunities for improving cancer studies

The results of the Cancer Medicines Forum workshop have been published in an article in theJournal of Cancer Policy. As a broad alliance of experts, we have developed a roadmap for the systematic implementation of cancer treatment optimization studies. I hope that this will advance the discussion on improving oncological studies and thus health care for patients, not only internationally but also here in Germany. At the time of marketing authorization, many questions regarding the optimal use of new cancer drugs remain unanswered. This concerns, for example, the appropriate dosage for different patient groups and treatment duration, but also the comparison of the available treatment options with each other, or the optimal sequence. Because